Ventana ALK IHC Test Gets FDA Approval as CDx for Pfizer's Xalkori | GenomeWeb

NEW YORK (GenomeWeb) – The US Food and Drug Administration has approved an immunohistochemistry companion diagnostic developed by Roche subsidiary Ventana Medical Systems, the firm announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.